What is MRNA's current stock price?

As of now, MRNA is trading at $35.53, with a daily change of +5.34%.

What are the risks associated with MRNA stock?

MRNA Key risk is its High Risk Level, .

What is MRNA next earnings date?

MRNA next earnings report is yet to be scheduled.

What is MRNA's current stock rating?

MRNA's current stock rating is Sell.

Should I buy MRNA stock right now?

Based on the current rating of Sell, it is advisable to consider Sell as your next step with MRNA stock.

Is MRNA a Strong Buy right now?

MRNA's current stock rating is Sell, which indicates whether it is a Strong Buy, Buy, Hold, Sell, or Strong Sell.

What does a 'Strong Buy' rating mean for MRNA?

A 'Strong Buy' rating for MRNA indicates that analysts are highly confident in the stock's potential for future growth.

What does a 'Strong Sell' rating mean for MRNA?

A 'Strong Sell' rating for MRNA suggests that analysts anticipate the stock will decline significantly and may not be a good investment.

What factors influence MRNA's stock rating?

MRNA's stock rating is influenced by factors such as market trends, earnings reports, risk factors, and overall sentiment from analysts.

Moderna (MRNA) Stock Analysis and Insights

LOGIN

Market Overview Trending Stocks Stock Screener Trade Ideas

Top Rated Most Active Strong Potential Positive Momentum Earnings Calendar

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist

MRNA

Moderna

$35.53

+$1.80 | +5.34%

Overview

Analysis

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Open

$ 33.89

MKT CAP

$ 13.67B

High

$ 35.97

VOL

$ 20.99M

Low

$ 33.18

AVG VOL

$ 13.56M

Chart

42.25

41.11

58.29

95.56

1year

6month

3month

1month

MRNA Latest Headlines +

Analyst Confident In Modernas Cancer Vaccine But Highlights Other Challenges. On Friday) reported a fourth-quarter EPS loss of $(2.91) missing the consensus of $(2.62) a turnaround from EPS.The COVID-19 vaccine maker reported quarterly sales of $966 million down from $2.81 billion a year ago beating the.Moderna has reiterated its 2025 revenue outlook of $1.5 billion to $2.5 billion versus a consensus of $2.43 billion. Moderna expects revenue of approximately $0.2 billion in the first half of the

Tue Feb 18, 2025

Activity

Should You Buy Hold or Sell Moderna Stock Post Q4 Earnings Release?. Given the uncertainty around its revenue growth we advise short-term investors to remain cautious when investing in MRNA stock.

Tue Feb 18, 2025

Momentum

Potential

Is Moderna Stock A Buy As Its CEO Fends Off RFK Jr. Concerns?. Moderna stock reversed losses on its fourth-quarter report after CEO Stephane Bancel deflected concerns over RFK Jr. Is MRNA stock a buy?The post Is Moderna Stock A Buy As Its CEO Fends Off RFK Jr. Concerns? appeared first on Investor'.s Business Daily.

Tue Feb 18, 2025

Activity

This Moderna Analyst Is No Longer ish. Here Are Top 5 Downgrades For Tuesday. Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes including upgrades downgrades and initiations please see our analyst ratings page.Morgan Stanley analyst Craig Hettenbach downgraded the rating for ) from Overweight to Equal-Weight and raised the price target from $42 to $60. Hims &. Hers Health shares closed at $60.47 on Friday. See how other analys

Tue Feb 18, 2025

Activity

Rating

Cancer Vaccines Market on Track for Major Expansion in the 7MM Amid Immunotherapy Advancements Predicts DelveInsight. Cancer Vaccines Market on Track for Major Expansion in the 7MM Amid Immunotherapy Advancements Predicts DelveInsight The cancer vaccine market is anticipated to experience substantial growth in the coming years. This growth is driven by the rising number of cancer diagnoses heightened awareness of cancer vaccines and the growing pipeline of cancer vaccines currently in clinical t

Mon Feb 17, 2025

Activity

Explore our MRNA Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored MRNA Stock Strategies
Effective Risk Management

FIND US ON

Receive our MRNA Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

Ideas

Earnings

Overview

Analysis

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

MRNA

Moderna

$35.53

+$1.80 | +5.34%

Chart

42.25

41.11

58.29

95.56

1year

6month

3month

1month

Discover MRNA Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of MRNA. We're here to help you make informed investment decisions today.

FIND US ON

Receive our MRNA Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

MRNA Stock trends

MRNA Stock performance

MRNA Stock analysis

MRNA investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

MRNA Stock Analysis for the Last 90 Days

MRNA Risk Level

MRNA Analysts Opinion

MRNA Street Consensus

MRNA Performance Sentiment

Technical Price Levels

MRNA Financial Health

Explore our MRNA Stock insights

Receive our MRNA Daily Alerts

MRNA Stock Analysis for the Last 90 Days

MRNA Street Consensus

Technical Price Levels

Discover MRNA Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of MRNA. We're here to help you make informed investment decisions today.

Receive our MRNA Daily Alerts